Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 22 - Number 3


Review Article (Mini-Review)

Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology

, 22(3): 254 - 281

Cristina Vieira, Lucas Nery, Ludimila Martins, Luiz Jabour, Raphael Dias and Ana Cristina Simões e Silva*


DOI: 10.2174/1389450121666201020154033



Review Article

Biopolymer-based Scaffolds for Tissue Engineering Applications

, 22(3): 282 - 295

Hitesh Chopra, Sandeep Kumar and Inderbir Singh*


DOI: 10.2174/1389450121999201102140408



Review Article

Application of Poloxamers for the Development of Drug Delivery System to Treat Leishmaniasis: A Review

, 22(3): 296 - 309

Audrey Silva, Amanda Costa, Sona Jain, Eduardo Coelho, Ricardo Fujiwara, Ricardo Scher, Rogéria Nunes and Silvio Dolabella*


DOI: 10.2174/1389450121666201106145022



Review Article

The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy

, 22(3): 310 - 317

Hamideh Sadat Mohammadipour, Fatemeh Forouzanfar and Ali Forouzanfar*


DOI: 10.2174/1389450121999201105152639



Review Article

A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents

, 22(3): 318 - 335

Gaurav Doshi* and Namrata Nailwal


DOI: 10.2174/1389450121666201020151927



Review Article

Pivotal Role of the Interaction Between Herbal Medicines and Gut Microbiota on Disease Treatment

, 22(3): 336 - 346

Tingting Zhao, Zhe Wang , Zhilong Liu and Youhua Xu *


DOI: 10.2174/1389450121666200324151530



Review Article

Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

, 22(3): 347 - 355

Roberto Gabbiadini, Eirini Zacharopoulou, Federica Furfaro, Vincenzo Craviotto, Alessandra Zilli, Daniela Gilardi, Giulia Roda, Laura Loy, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese and Mariangela Allocca*


DOI: 10.2174/1389450121666201119142919



Book Reviews



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog